324 related articles for article (PubMed ID: 9801104)
1. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study.
Naughton CK; Smith DS; Humphrey PA; Catalona WJ; Keetch DW
Urology; 1998 Nov; 52(5):808-13. PubMed ID: 9801104
[TBL] [Abstract][Full Text] [Related]
2. Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores.
Grossklaus DJ; Coffey CS; Shappell SB; Jack GS; Cookson MS
BJU Int; 2001 Nov; 88(7):722-6. PubMed ID: 11890243
[TBL] [Abstract][Full Text] [Related]
3. [Transrectal ultrasound-guided prostatic biopsy: contribution of an ultrasound diagnostic unit after ten years of experience].
Rodríguez-Patrón Rodríguez R; Mayayo Dehesa T; García González R; Arias Fúnez F; Lennie Zuccarino A; Sanz Mayayo E
Arch Esp Urol; 2006 May; 59(4):397-406. PubMed ID: 16800137
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of transrectal ultrasound-guided prostate biopsy, targeting eight cores, for detecting prostate cancer in Japanese men.
Ishimura T; Sakai I; Hara I; Eto H; Miyake H
Int J Clin Oncol; 2004 Feb; 9(1):47-50. PubMed ID: 15162826
[TBL] [Abstract][Full Text] [Related]
5. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors?
Chan TY; Chan DY; Stutzman KL; Epstein JI
J Urol; 2001 Dec; 166(6):2181-4. PubMed ID: 11696731
[TBL] [Abstract][Full Text] [Related]
6. A prospective study analysing the effect of pain on probe insertion, and the biopsy strategy, on the patients' perception of pain during TRUS-guided biopsy of the prostate.
Chopra S; Rowe EW; Laniado M; Patel A
N Z Med J; 2008 Dec; 121(1287):39-43. PubMed ID: 19098966
[TBL] [Abstract][Full Text] [Related]
7. The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasound-guided prostate biopsies.
Pryor MB; Schellhammer PF
Clin Prostate Cancer; 2002 Dec; 1(3):172-6. PubMed ID: 15046692
[TBL] [Abstract][Full Text] [Related]
8. The Efficacy of Transrectal Ultrasound Guided Biopsy Versus Transperineal Template Biopsy of the Prostate in Diagnosing Prostate Cancer in Men with Previous Negative Transrectal Ultrasound Guided Biopsy.
Nafie S; Wanis M; Khan M
Urol J; 2017 Mar; 14(2):3008-3012. PubMed ID: 28299763
[TBL] [Abstract][Full Text] [Related]
9. Prostate biopsy: who, how and when. An update.
Djavan B; Milani S; Remzi M
Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
[TBL] [Abstract][Full Text] [Related]
10. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
[TBL] [Abstract][Full Text] [Related]
11. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
12. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
[TBL] [Abstract][Full Text] [Related]
13. Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms.
Gancarczyk KJ; Wu H; McLeod DG; Kane C; Kusuda L; Lance R; Herring J; Foley J; Baldwin D; Bishoff JT; Soderdahl D; Moul JW
Urology; 2003 Mar; 61(3):589-95. PubMed ID: 12639653
[TBL] [Abstract][Full Text] [Related]
14. Increasing prostate biopsy cores based on volume vs the sextant biopsy: a prospective randomized controlled clinical study on cancer detection rates and morbidity.
Mariappan P; Chong WL; Sundram M; Mohamed SR
BJU Int; 2004 Aug; 94(3):307-10. PubMed ID: 15291857
[TBL] [Abstract][Full Text] [Related]
15. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
Eskicorapci SY; Guliyev F; Akdogan B; Dogan HS; Ergen A; Ozen H
J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481
[TBL] [Abstract][Full Text] [Related]
16. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
King CR; McNeal JE; Gill H; Presti JC
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
[TBL] [Abstract][Full Text] [Related]
17. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
Smart R
N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
[TBL] [Abstract][Full Text] [Related]
19. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
[TBL] [Abstract][Full Text] [Related]
20. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer.
Epstein JI; Walsh PC; Sauvageot J; Carter HB
J Urol; 1997 Nov; 158(5):1886-90. PubMed ID: 9334623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
